Skip to content

Identification of a risk profile to guide atrial fibrillation therapy

Identification of a risk profile to guide atrial fibrillation therapy - AF risk profile

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON35975
Enrollment
500
Registered
2011-05-26
Start date
2011-05-26
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Short-lasting symptomatic paroxysmal or persistent AF 2. Rhythm control strategy is preferred 3. No contra-indication for oral anticoagulation 4. Age > 18 years

Exclusion criteria

Exclusion criteria: 1. Total history of heart failure and/ or of severe valvular disease > 3 years 2. Severe valvular disease 3. Acute coronary syndrome/ myocardial infarction/ percutaneous coronary intervention/ coronary artery bypass surgery within the past one month 4. Post-operative AF

Design outcomes

Primary

MeasureTime frame
Success of rhythm control.

Secondary

MeasureTime frame
1. Time to recurrence of (a)symptomatic AF. 2. Failure of rhythm control, i.e. permanent AF. 3. Risk profiles associated with early versus late AF recurrence. 4. Progression of paroxysmal AF to persistent or permanent AF and of persistent AF to permanent AF. 5. Changes in atrial and ventricular echocardiographic parameters. 6. Cardiovascular morbidity and mortality. 7. Pulmonary vein ablation.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)